The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil.
Open accessAbstract
Uracil analogues with appropriate substituents at the 5-position inactivated dihydropyrimidine dehydrogenase (DHPDHase). The efficiency of these inactivators was highly dependent on the size of the 5-substituent. For example, 5-ethynyluracil inactivated DHPDHase with an efficiency (kinact/Ki) that was 500-fold greater than that for 5-propynyluracil. 5-Ethynyluracil inactivated DHPDHase by initially forming a reversible complex with a Ki of 1.6 +/- 0.2 microM. This initial complex yielded inactivated enzyme with a rate constant of 20 +/- 2 min-1 (kinact). Thymine competitively decreased the apparent rate constant for inactivation of DHPDHase by 5-ethynyluracil. The absorbance spectrum of 5-ethylnyluracil-inactivated DHPDHase was different from that of reduced enzyme. These optical changes were correlated with the loss of enzymatic activity. 5-Ethynyluracil inactivated DHPDHase with a stoichiometry of 0.9 mol of inactivator per mol of active site. Enzyme inactivated with [2-14C]5-ethynyluracil retained all of the radiolabel after denaturation in 8 M urea, but lost radiolabel under acidic conditions. These results suggested that inactivation was due to covalent modification of an amino acid residue and not due to modification of a noncovalently bound prosthetic group. A radiolabeled peptide was isolated from a tryptic digest of the enzyme inactivated with [2-14C]5-ethynyluracil. The sequence of this peptide was Lys-Ala-Glu-Ala-Ser-Gly-Ala-Y-Ala-Leu-Glu-Leu-Asn-Leu-Ser-X-Pro-His-Gly- Met-Gly-Glu-Arg, where X and Y were unidentified amino acids. Since the radiolabel was lost from the peptide during the first cycle on the amino acid sequenator, the position of the radiolabeled amino acid was not determined. The amino acid residue designated by X was identified as a cysteine from previous work with DHPDHase inactivated with 5-iodouracil. In contrast to 5-ethynyluracil, 5-cyanouracil was a reversible inactivator of the enzyme. 5-Cyanouracil-inactivated enzyme slowly regained activity (t1/2 = 1.8 min) after dilution into the standard assay. DHPDHases isolated from rat, mouse, and human liver had similar sensitivities to inactivation by 5-alkynyluracils.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, studies have reported that DPD inhibitors such as 5-ethynyluracil and 5-chloro-2,4-dihydroxypyridine (CDHP) can improve the anti-tumor activity of 5-FU to a greater extent [100,101,102].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [100]
Citations
Cites
Data Reduction and Error Analysis for the Physical Sciences
Bevington, P. R., Robinson, D. K., Blair, J. M., Mallinckrodt, A. J., & McKay, S. (1993) · Computers in Physics · doi:10.1063/1.4823194 · Cited by 14,824
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Suicide substrates: mechanism-based enzyme inactivators
Walsh, C. (1982) · Tetrahedron · doi:10.1016/0040-4020(82)85068-0 · Cited by 447
Fluorescence and optical characteristics of reduced flavines and flavoproteins
Ghisla, S., Massey, V., Lhoste, J.-M., & Mayhew, S. G. (1974) · Biochemistry · doi:10.1021/bi00700a029 · Cited by 386
Abeles, R. H., & Maycock, A. L. (1976) · Accounts of Chemical Research · doi:10.1021/ar50105a001 · Cited by 369
The chemistry of the ether linkage
Patai, S. (1967) · Interscience Publishers eBooks · Cited by 306
Purine nucleoside synthesis: an efficient method employing nucleoside phosphorylases
Krenitsky, T. A., Koszalka, G. W., & Tuttle, J. V. (1981) · Biochemistry · doi:10.1021/bi00515a048 · Cited by 191
Maycock, A. L., Abeles, R. H., Salach, J. I., & Singer, T. P. (1976) · Biochemistry · doi:10.1021/bi00646a018 · Cited by 128
Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influences
Wasternack, C. H. (1980) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(80)90079-0 · Cited by 114
Purification and properties of dihydrothymine dehydrogenase from rat liver.
Shiotani, T., & Weber, G. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70122-7 · Cited by 112
Research works printed but not linked: 3
- Tatsumi, 1987, Jpn. Cancer Res., 78, 748
- Desgranges, 1986, Cancer Res., 45, 1094
- Cooper, 1970, Cancer Res., 30, 2937
Cited by
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Mammalian deoxyribonucleoside kinases
Arnér, E. S. J., & Eriksson, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00015-9 · Cited by 577
Basis for effective combination cancer chemotherapy with antimetabolites
Peters, G. J., van der Wilt, C. L., van Moorsel, C. J. A., Kroep, J. R., Bergman, A. M., & Ackland, S. P. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00086-3 · Cited by 301
Sgambellone, M. A., David, A., Garner, R. N., Dunbar, K. R., & Turro, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4045604 · Cited by 217
Metadata
- Authors
- Porter, D. J., Chestnut, W. G., Merrill, B. M., & Spector, T.
- ORCID
- Porter, D.J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1992-03
- Volume
- 267
- Issue
- 8
- Pages
- 5236-5242
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1580716972
- Cited by
- 123
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2018: 2 · 2017: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 10455 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- dihydropyrimidine dehydrogenase, enzyme inactivation, uracil analogues, covalent modification, cysteine residues, radiolabeled peptides, 5-iodouracil
- MeSH terms
- Amino Acid Sequence, Animals, Cattle, Dithiothreitol, Humans, Kinetics, Liver, Mathematics, Molecular Sequence Data, Oxidoreductases, Peptide Fragments, Structure-Activity Relationship, Uracil, Dihydrouracil Dehydrogenase (NADP), Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. https://app.cochat.ai/papers/10.1016/s0021-9258(18)42757-3
- The paper
- Porter, D. J., Chestnut, W. G., Merrill, B. M., & Spector, T. (1992). Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(18)42757-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.